驱动力(838275) - 投资者关系活动记录表

Group 1: Investor Relations Activity Overview - The investor relations activity was held on December 5, 2024, at the company meeting room [2] - Attendees included various investment firms and individual investors [2] - Company representatives included the Chairman, General Manager, and other key executives [3] Group 2: Company Business and Market Insights - The company has previously engaged in the pet food sector, but this currently represents a small portion of its business [4] - There is significant market demand for hematopoietic nutritional products due to modern farming practices leading to anemia in livestock [5] - The company's main business involves developing and selling additives that enhance animal blood production, but its market share remains relatively small [6] Group 3: Financial Performance and Projections - The company's gross profit margin increased in the first three quarters of 2024 due to a shift in focus towards higher-margin products [7] - Despite a decline in revenue, net profit increased in 2024, attributed to improved sales structure and reduced credit impairment losses [8] - The company aims to continue innovation and market expansion to enhance performance and returns for investors [9]